Luna, Alaiza A.
HRN: 22-95-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/28/2023
05/04/2023
IV
2.25g
Q6Hrs
Septic Shock; AGE With Severe Dehydration
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes